Production / Operations
MindBio Deploys Engineers to South American Mining Industry, Accelerates Investment in Enterprise Voice AI Health Diagnostics.

MBIO · Price
Executive Summary
- MindBio Therapeutics announced the deployment of a software‑engineering team to Chile to develop a voice‑analytics platform for drug and alcohol screening in the mining industry.
- The solution aims to provide scalable, non‑invasive intoxication detection for mining, aviation, construction and other high‑risk workplaces.
- CEO Justin Hanka highlighted the large market opportunity in South America, citing high rates of substance use among miners and the associated safety risks.
Key Details
- Deployment: A team of software engineers has been sent to Chile to work with health and mining officials on a practical protocol for voice‑based drug and alcohol screening.
- Target Industries: Initial focus on the mining sector in Chile, with plans to expand to other South American countries and globally across mining, aviation, construction, law enforcement, mental health and telehealth.
- Technology: Voice‑analytics AI platform that predicts intoxication from speech patterns; trained on over 50 million data points, currently validated for alcohol detection and being expanded to other substances.
- Market Insight (Chile):
-
75 % of mining workers consume alcohol; >40 % are problem drinkers.
- Drug use estimated at ~9 % among the >200,000 miners surveyed.
- International data links 20‑25 % of occupational accidents to substance use.
- Strategic Rationale: First‑mover advantage in voice‑activated AI health diagnostics; heavy investment to develop scalable workplace safety solutions.
- Future Plans: After establishing the solution in Chile, MindBio intends to roll out the platform throughout South America and eventually worldwide.
Notable Quotes
“MindBio is seizing its first mover advantage in voice activated AI digital health diagnostics by investing heavily to develop scalable solutions for workplace health and safety related to drug and alcohol intoxication.” – Justin Hanka, CEO
Materiality Assessment: Non‑Material – Positive (operational update with potential future revenue impact but no immediate financial or earnings information).
More from MindBio Therapeutics Corp.
Jun 09, 2026 · 07:00